Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer
- PMID: 22586430
- PMCID: PMC3347037
- DOI: 10.3389/fimmu.2012.00107
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer
Abstract
The inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory disorders of the intestine. The prevalence in the United States is greater than 200 cases per 100,000, with the total number of IBD patients between 1 and 1.5 million. CD may affect all parts of the gastrointestinal tract, from mouth to anus, but most commonly involves the distal part of the small intestine or ileum, and colon. UC results in colonic inflammation that can affect the rectum only, or can progress proximally to involve part of or the entire colon. Clinical symptoms include diarrhea, abdominal pain, gastrointestinal bleeding, and weight loss. A serious long-term complication of chronic inflammation is the development of colorectal cancer. A genetic basis for IBD had long been recognized based on the increased familial risk. However, significant discordance for CD in twins, and a much less robust phenotypic concordance for UC, suggested additional factors play a role in disease pathogenesis, including environmental factors. In the past several years, progress in understanding the molecular basis of IBD has accelerated, beginning with the generation of animal models of colitis and progressing to the identification of specific genetic markers from candidate gene, gene linkage, and genome-wide association analyses. Genetic studies have also resulted in the recognition of the importance of environmental factors, particularly the crucial role of the gut microbiota in CD and UC. Altered immune responses to the normal intestinal flora are key factors in IBD pathogenesis. In this research topic, the genetic basis of IBD, the genetic and cellular alterations associated with colitis-associated colon cancer, and the emerging role of the intestinal microbiota and other environmental factors will be reviewed.
Keywords: Crohn’s disease; chronic intestinal inflammation; colitis-associated colon cancer; inflammatory bowel disease; ulcerative colitis.
Similar articles
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5. Acta Dermatovenerol Croat. 2016. PMID: 27149138
-
Investigating intestinal inflammation in DSS-induced model of IBD.J Vis Exp. 2012 Feb 1;(60):3678. doi: 10.3791/3678. J Vis Exp. 2012. PMID: 22331082 Free PMC article.
-
Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease.mSphere. 2021 Jan 13;6(1):e01185-20. doi: 10.1128/mSphere.01185-20. mSphere. 2021. PMID: 33441404 Free PMC article.
-
Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation.Cureus. 2022 Feb 26;14(2):e22636. doi: 10.7759/cureus.22636. eCollection 2022 Feb. Cureus. 2022. PMID: 35371788 Free PMC article. Review.
Cited by
-
Gut microbiota in health and disease: advances and future prospects.MedComm (2020). 2024 Nov 20;5(12):e70012. doi: 10.1002/mco2.70012. eCollection 2024 Dec. MedComm (2020). 2024. PMID: 39568773 Free PMC article. Review.
-
NLRP3 Inflammasome and Gut Dysbiosis Linking Diabetes Mellitus and Inflammatory Bowel Disease.Arch Intern Med Res. 2024;7(3):200-218. doi: 10.26502/aimr.0178. Epub 2024 Aug 31. Arch Intern Med Res. 2024. PMID: 39328924 Free PMC article.
-
Anti-Inflammatory Effect of Korean Soybean Sauce (Ganjang) on Mice with Induced Colitis.J Microbiol Biotechnol. 2024 Jul 28;34(7):1501-1510. doi: 10.4014/jmb.2404.04020. Epub 2024 Jun 11. J Microbiol Biotechnol. 2024. PMID: 38960873 Free PMC article.
-
Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation.Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2312111121. doi: 10.1073/pnas.2312111121. Epub 2024 Apr 24. Proc Natl Acad Sci U S A. 2024. PMID: 38657041 Free PMC article.
-
Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study.Microb Cell. 2024 Mar 14;11:79-89. doi: 10.15698/mic2024.03.817. eCollection 2024. Microb Cell. 2024. PMID: 38486888 Free PMC article.
References
-
- Anderson C. A., Massey D. C., Barrett J. C., Prescott N. J., Tremelling M., Fisher S. A., Gwilliam R., Jacob J., Nimmo E. R., Drummond H., Lees C. W., Onnie C. M., Hanson C., Blaszczyk K., Ravindrarajah R., Hunt S., Varma D., Hammond N., Lewis G., Attlesey H., Watkins N., Ouwehand W., Strachan D., McArdle W., Lewis C. M.; Wellcome Trust Case Control Consortium, Lobo, A., Sanderson J., Jewell D. P., Deloukas P., Mansfield J. C., Mathew C. G., Satsangi J., Parkes M. (2009). Investigation of Crohn’s disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136 523–529e3 - PMC - PubMed
-
- Aust D. E., Terdiman J. P., Willenbucher R. F., Chang C. G., Molinaro-Clark A., Baretton G. B., Loehrs U., Waldman F. M. (2002). The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 94 1421–1427 - PubMed
-
- Backhed F., Ley R. E., Sonnenburg J. L., Peterson D. A., Gordon J. I. (2005). Host–bacterial mutualism in the human intestine. Science 307 1915–1920 - PubMed
-
- Barrett J. C., Hansoul S., Nicolae D. L., Cho J. H., Duerr R. H., Rioux J. D., Brant S. R., Silverberg M. S., Taylor K. D., Barmada M. M., Bitton A., Dassopoulos T., Datta L. W., Green T., Griffiths A. M., Kistner E. O., Murtha M. T., Regueiro M. D., Rotter J. I., Schumm L. P., Steinhart A. H., Targan S. R., Xavier R. J.; NIDDK IBD Genetics Consortium, Libioulle, C., Sandor C., Lathrop M., Belaiche J., Dewit O., Gut I., Heath S., Laukens D., Mni M., Rutgeerts P., Van Gossum A., Zelenika D., Franchimont D., Hugot J. P., de Vos M., Vermeire S., Louis E.; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium, Cardon, L. R., Anderson C. A., Drummond H., Nimmo E., Ahmad T., Prescott N. J., Onnie C. M., Fisher S. A., Marchini J., Ghori J., Bumpstead S., Gwilliam R., Tremelling M., Deloukas P., Mansfield J., Jewell D., Satsangi J., Mathew C. G., Parkes M., Georges M., Daly M. J. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40 955–962 - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous